15.13

1.63% -0.23

Celcuity Inc (CELC)

Overview News Price History Option Chain Financials Discussions Forecast

Celcuity Inc stock is traded at $15.13, with a volume of 40,820. It is down -1.63% in the last 24 hours and up +0.47% over the past month. Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Previous Close:

$15.36

Open:

$15.33

24h Volume:

40,820

Relative Volume:

0.17

Market Cap:

$559.16M

Revenue:

Net Income/Loss:

$-63.78M

P/E Ratio:

-5.7094

EPS:

-2.65

Net Cash Flow:

$-53.91M

1W Performance:

-5.03%

1M Performance:

+0.47%

6M Performance:

-14.49%

1Y Performance:

+41.48%

1-Day Range:

$14.83

$15.39

1-Week Range:

$14.58

$16.26

52-Week Range:

$9.99

$22.19

Celcuity Inc Stock (CELC) Company Profile

Name

Celcuity Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

763-392-0767

Address

16305 36TH AVENUE N, MINNEAPOLIS, MN

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

CELC's Discussions on Twitter

Celcuity Inc Stock (CELC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-22-24	Initiated	Leerink Partners	Outperform
Feb-22-24	Initiated	Stifel	Buy
Dec-08-23	Initiated	H.C. Wainwright	Buy
Oct-08-21	Initiated	Canaccord Genuity	Buy
Sep-07-21	Initiated	Jefferies	Buy
Jul-29-21	Initiated	Cowen	Outperform
Jul-27-21	Initiated	Needham	Buy
Jan-28-21	Reiterated	H.C. Wainwright	Buy
Dec-24-20	Reiterated	H.C. Wainwright	Buy
May-11-20	Resumed	Craig Hallum	Buy
Nov-20-18	Initiated	H.C. Wainwright	Buy

View All

Celcuity Inc Stock (CELC) Latest News

Oct 31, 2024

Celcuity director Buller sells $5,687 in stock By Investing.com - Investing.com Australia

Oct 26, 2024

Oct 20, 2024

Objective long/short (CELC) Report - Stock Traders Daily

Oct 20, 2024

Oct 14, 2024

Short Interest in Celcuity Inc. (NASDAQ:CELC) Rises By 26.7% - MarketBeat

Oct 14, 2024

Oct 11, 2024

Celcuity Inc. expands share authorization to 95 million By Investing.com - Investing.com Australia

Oct 11, 2024

Oct 10, 2024

Celcuity Inc. expands share authorization to 95 million - Investing.com India

Oct 10, 2024

Celcuity (NASDAQ:CELC) Files 8-K Disclosing Change in Directors or Principal Officers - MarketBeat

Oct 10, 2024

Oct 09, 2024

Celcuity (NASDAQ:CELC) Stock Price Down 4.5%Here's What Happened - MarketBeat

Oct 09, 2024

Oct 07, 2024

Morgan Stanley's Strategic Reduction in Celcuity Inc Holdings - GuruFocus.com

Oct 07, 2024

Stifel raises Celcuity stock price target, maintains buy on sales potential - Investing.com

Oct 07, 2024

Celcuity (NASDAQ:CELC) PT Raised to $42.00 at Stifel Nicolaus - MarketBeat

Oct 07, 2024

Oct 06, 2024

Brokerages Set Celcuity Inc. (NASDAQ:CELC) PT at $28.67 - MarketBeat

Oct 06, 2024

Oct 04, 2024

Point72 Asset Management L.P. Buys New Position in Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Oct 04, 2024

Sep 30, 2024

Driehaus Capital Management LLC Purchases 78,525 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Sep 30, 2024

Sep 29, 2024

Celcuity Inc. (NASDAQ:CELC) Short Interest Up 11.4% in September - MarketBeat

Sep 29, 2024

(CELC) Investment Report - Stock Traders Daily

Sep 29, 2024

Sep 28, 2024

Blue Owl Capital Holdings LP Takes $1.07 Million Position in Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Sep 28, 2024

Sep 24, 2024

Samlyn Capital LLC Purchases 637,190 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World

Sep 24, 2024

Celcuity Inc. (NASDAQ:CELC) Shares Acquired by Samlyn Capital LLC - MarketBeat

Sep 24, 2024

Sep 23, 2024

It is Poised to be a Bull Market for Celcuity Inc (CELC) - SETE News

Sep 23, 2024

Sep 18, 2024

(CELC) Technical Pivots with Risk Controls - Stock Traders Daily

Sep 18, 2024

Sep 17, 2024

Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat

Sep 17, 2024

Sep 16, 2024

Ratios Revealed: Decoding Celcuity Inc (CELC)’s Financial Health - The Dwinnex

Sep 16, 2024

Sep 13, 2024

Celcuity (NASDAQ:CELC) Sees Large Volume Increase - MarketBeat

Sep 13, 2024

Sep 12, 2024

Celcuity (NASDAQ:CELC) Shares Down 3.5% - MarketBeat

Sep 12, 2024

Sep 11, 2024

Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Sep 11, 2024

Celcuity Inc. (NASDAQ:CELC) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Sep 11, 2024

Sep 10, 2024

Celcuity (CELC) Holds a Potential Game-changer in Cancer Treatment - Nasdaq

Sep 10, 2024

Can Celcuity (CELC) Climb 87.59% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance

Sep 10, 2024

Sep 02, 2024

How To Trade (CELC) - Stock Traders Daily

Sep 02, 2024

Ready to Jump After Recent Trade: Celcuity Inc (CELC) - SETE News

Sep 02, 2024

Aug 31, 2024

Is Celcuity (NASDAQ:CELC) Using Too Much Debt? - Simply Wall St

Aug 31, 2024

Aug 28, 2024

Celcuity director sells shares worth $5,932 By Investing.com - Investing.com Australia

Aug 28, 2024

Celcuity director sells shares worth $5,932 - Investing.com India

Aug 28, 2024

Aug 26, 2024

Celcuity (NASDAQ:CELC) Coverage Initiated by Analysts at Lifesci Capital - MarketBeat

Aug 26, 2024

Celcuity (NASDAQ:CELC) Now Covered by Lifesci Capital - Defense World

Aug 26, 2024

Wall Street analysts’ outlook for Celcuity Inc (CELC) - SETE News

Aug 26, 2024

LifeSci Capital Initiates Coverage of Celcuity (CELC) with Outperform Recommendation - MSN

Aug 26, 2024

Aug 23, 2024